Browse Items (4 total)
- Tags: Scalera N M
Hospital Readmissions in Patients With Carbapenem-Resistant Klebsiella pneumoniae
Tags: 2016, Antibacterial Resistance Leadershi, Bonomo R A, carriage, Cober E, Department of Internal Medicine, Doi Y H, efficacy, emergence, Enterobacteriaceae, Environmental & Occupational Health, Epidemiology, Evans S, Fowler V G, Infection control and hospital epidemiology, Infectious Diseases, Journal Article or Conference Abstract Publication, Kalayjian R C, Kaye K S, Messina J A, metaanalysis, NEOMED College of Medicine, outbreak, outcomes, Perez F, Public, Richter S S, Salata R A, Scalera N M, therapy, Tigecycline, van Duin D, Watkins R
How long should we treat community-acquired pneumonia?
Tags: 2007, antibacterial response, antibiotic-therapy, antimicrobial therapy, azithromycin, clinical-efficacy, Community-acquired pneumonia, Current opinion in infectious diseases, double-blind, duration of therapy, File T M, Infectious Diseases, Journal Article, Practice Guidelines, respiratory-tract infections, Scalera N M, short-duration therapy, Streptococcus pneumoniae
Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections.
Tags: *beta-Lactam Resistance, 2016, 80 and over, Aged, Bacteremia/microbiology/mortality, Bacterial/microbiology/mortality, Bonomo R A, carbapenem-resistant Enterobacteriaceae, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, Cober E, Department of Internal Medicine, Doi Y, Epidemiology, Evans S, Female, Fowler V G Jr, Hauck C, Humans, Kalayjian R C, Kaye K S, Klebsiella Infections/*microbiology/*mortality, Klebsiella pneumoniae, Klebsiella pneumoniae/*drug effects/isolation & purification, Longitudinal Studies, Male, Middle Aged, Mortality, NEOMED College of Medicine, Perez F, Pneumonia, Prospective Studies, Richter S S, Salata R A, Scalera N M, Survival Analysis, Urinary Tract Infections/microbiology/mortality, van Duin D, Watkins R R